Profilo
Barbara Domayne Hayman is currently an Investment Committee member at Cambridge Enterprise Ltd. and the Chief Business Officer at Autifony Therapeutics Ltd. She holds a doctorate degree from the University of Oxford.
Posizioni attive di Barbara Domayne Hayman
| Società | Posizione | Inizio |
|---|---|---|
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Membro del Comitato di Investimento | - |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Corporate Officer/Principal | - |
Formazione di Barbara Domayne Hayman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Finance |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Health Technology |
















